Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. .TMU Publications / 北醫出版品(教師升等著作 / 教學實踐 / 學位論文)
  3. .博碩士學位論文
  4. 114學年度
  5. CDK4/6抑制劑於HER2低表現轉移性乳癌之真實世界療效分析
 
  • Details
Options

CDK4/6抑制劑於HER2低表現轉移性乳癌之真實世界療效分析

Other Title
Real-World Effectiveness of CDK4/6 Inhibitors in Patients with HER2-Low Metastatic Breast Cancer
Type
thesis
Date Issued
2026-06-18
Author(s)
劉宇昕
Advisor
戈鈺
Subjects
系所名稱:藥學系臨床藥學碩士在職專班
Publisher
藥學系臨床藥學碩士在職專班
Description
學位別:碩士
語文別:英文
指導教授:戈鈺
口試委員:王莉萱; 吳天元; 戈鈺
授權範圍:網際網路,開放日期為2026-07-02
電子論文連結:https://handle.ncl.edu.tw/11296/zee5a5
URI
https://handle.ncl.edu.tw/11296/zee5a5
https://203.71.86.71/handle/123456789/74303

Copyright Notice

● The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use.

● Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner. Users must not use TMUIR for any illegal purposes.

● By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in this statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions.

● TMUIR is committed to protecting the interests of copyright owners. If you believe that any material on this website infringes copyright, please contact our staff at libirtmu@gmail.com, and we will remove the work from the repository.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback